Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma

BackgroundCutaneous squamous cell carcinoma (CSCC) of the head and neck can require complex and disfiguring surgery in order to achieve cure, which can be morbid and negatively impact patient quality of life. The management of advanced CSCC has been revolutionized by immunotherapy with current clini...

Full description

Bibliographic Details
Main Authors: Luke S. McLean, Annette M. Lim, Angela Webb, Karda Cavanagh, Alesha Thai, Matthew Magarey, Carly Fox, Stephen Kleid, Danny Rischin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
cutaneous squamous cell carcinoma
orbital exenteration
anti-PD1
pseudoprogression
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.796197/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.796197/full

Similar Items